Australia's largest stock trading and investment forum Australia's #1 stock forum

RGT

Click for more information

51.4%

53.0¢ argent biopharma limited

Ann: Chairman's Update to Shareholders-MXC.AX, page-33

First 33 Last

Share
Profile

Follow
Cbyrne11

1,776 Posts.

36

27/05/16

13:39

Post #: 17884709
Share

Originally posted by redgie321 ↑

Sure, but from a sales perspective "FDA approved" will no doubt carry a lot of weight in the consumers mind.

I am with you on the reference to the 'it not being a drug' aspect, but it will serve it's purpose as has been seen by the SP remaining ~25% above the PRO issue price upon the release of that ANN. Again, bravo management on a solid play.

Expand

True, that will help, the main thing is going to be position and branding it in the market, they are selling it at premium prices, so the actual product better be premium, it looks it at the moment.

MXC Price at posting: 5.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

IRE

Iress runs 'hot' for Wealth Within's stock tips

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Failure to report prompts ASX to impose multiple company suspensions

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 39 more messages in this thread...

First 33 Last

Add RGT (ASX) to my watchlist

(20min delay)
Last 53.0¢		Change 0.180(51.4%)		Mkt cap ! $25.65M

Open	High	Low	Value	Volume
38.0¢	56.0¢	38.0¢	$71.38K	137.5K

Buyers (Bids)

No.	Vol.	Price($)
1	334	51.0¢

Sellers (Offers)

Price($)	Vol.	No.
55.0¢	60	1

View Market Depth

No.	Vol.	Price($)
1	334	0.510
1	680	0.470
1	2000	0.460
1	5000	0.450
2	9000	0.445

Price($)	Vol.	No.
0.550	60	1
0.590	2000	1
0.620	1414	1
0.700	1368	1
0.740	350	1

Last trade - 16.10pm 01/10/2024 (20 minute delay)

RGT (ASX) Chart

SPONSORED BY